Type 2 idiopathic macular telangiectasia: Long-term visual prognosis and incidence of subretinal neovascularization

Retina

Volumn 32, Issue 2, 2012, Pages 265-274

  Shukla, Dhananjay ^a   Gupta, Shashank R ^a   Neelakantan, Nithya ^b   Tiwari, Sachin ^a   Gupta, Sumi ^a   Patwardhan, Aditi R ^a   Soubhya, Thayyil B ^b  

^a ARAVIND EYE HOSPITAL   (India)

^b Lions Aravind Institute of Community Ophthalmology   (India)

Author keywords

fluorescein angiography; foveal atrophy; idiopathic juxtafoveolar retinal telangiectasis; idiopathic macular telangiectasia; natural history; subretinal neovascularization

Indexed keywords

ADULT; AGED; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OUTPATIENT; PIGMENT EPITHELIUM; PROGNOSIS; RETINA FLUORESCEIN ANGIOGRAPHY; RETINAL TELANGIECTASIA; RETINOPATHY; REVIEW; SUBRETINAL NEOVASCULARIZATION; TYPE 2 IDIOPATHIC MACULA TELANGIECTASIA; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AGED; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETINAL NEOVASCULARIZATION; RETINAL TELANGIECTASIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISUAL ACUITY;

EID: 84856614475     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31822091b0     Document Type: Review

References (25)

1. Yannuzzi JA, Bardal AMC, Freund KB, et al. Idiopathic macular telangiectasia. Arch Ophthalmol 2006;124:450-460.
2. Gass JD, Oyakawa RT. Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 1982;100:769-780. (Pubitemid 12156592)
3. Gass JDM, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis: update of classification and follow-up study. Ophthalmology 1993;1536-1546. (Pubitemid 23292864)
4. Chew EY. Parafoveal telangiectasis. In: Ryan SJ, Hinton DR, Schachat AP, Wilkinson CP, eds. Retina. 4th ed. Vol 2. Philadelphia, PA: Elsevier; 2006:1409-1415.
5. Charbel Issa P, Scholl HP, Helb HM, Holz FG. Idiopathic macular telangiectasia. In: Holz FG, Spaide RF, eds. Medical Retina. Berlin: Springer; 2007:183-197.
6. Gillies MC. Progress report: the MacTel project. Retina Today 2010;5:35-37.
7. Clemons TE, Gillies MC, Chew EY, et al. Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel): MacTel Project Report No. 2. Ophthalmic Epidemiol 2010;17:66-73.
8. Klein R, Blodi BA, Meuer SM, et al. The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study. Am J Ophthalmol 2010;150:55-62.
9. Tewari HK, Wagh VB, Sony P, et al. Macular thickness evaluation using the optical coherence tomography in normal Indian eyes. Indian J Ophthalmol 2004;52:199-204. (Pubitemid 39349845)
10. Watzke RC, Klein ML, Folk JC, et al. Long term juxtafoveal retinal telangiectasia. Retina 2005;25:727-735. (Pubitemid 41254542)
11. Charbel Issa P, Helb HM, Holz FG, et al. Correlation of macular function with retinal thickness in non-proliferative type 2 idiopathic macular telangiectasia. Am J Ophthalmol 2008;145:169-175.
12. Cohen SM, Cohen ML, El-Jabali F, Pautler SE. Optical coherence tomography findings in nonproliferative group 2A idiopathic juxtafoveal retinal telangiectasis. Retina 2007;27:59-66. (Pubitemid 46095832)
13. Charbel Issa P, Holz FG, Scholl HP. Metamorphopsia in patients with macular telangiectasia type 2. Doc Ophthalmol 2009;119:133-140.
14. Schmitz-Valckenberg S, Fan K, Nugent A, et al. Correlation of functional impairment and morphological alterations in patients with group 2A idiopathic juxtafoveal retinal telangi-ectasia. Arch Ophthalmol 2008;126:330-335. (Pubitemid 351398455)
15. Maruko I, Iida T, Sekiryu T, Fujiwara T. Early morphological changes and functional abnormalities in group 2A idiopathic juxtafoveolar retinal telangiectasis using spectral domain optical coherence tomography and microperimetry. Br J Ophthalmol 2008;92:1488-1491.
16. Albini TA, Benz MS, Coffee RE, et al. Optical coherence tomography of idiopathic juxtafoveolar telangiectasia. Ophthalmic Surg Lasers Imaging 2006;37:120-128.
17. Sanchez JG, Garcia RA, Wu L, et al. Optical coherence tomography characteristics of group 2A idiopathic parafoveal telangiectasis. Retina 2007;27:1214-1220. (Pubitemid 350211527)
18. Gaudric A, Ducos de Lahitte G, Cohen SY, et al. Optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telan-giectasis. Arch Ophthalmol 2006;124:1410-1419. (Pubitemid 44537141)
19. Helb HM, Charbel Issa P, Van Der Veen RL, et al. Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia. Retina 2008;28:808-816.
20. Gillies MC, Zhu M, Chew E, et al. Familial asymptomatic macular telangiectasia type 2. Ophthalmology 2009;116:2422-2429.
21. Engelbrecht NE, Aaberg TM Jr, Sung J, Lewis ML. Neovascular membranes associated with idiopathic juxtafoveolar telangiec-tasis. Arch Ophthalmol 2002;120:320-324. (Pubitemid 34250052)
22. Yannuzzi LA, Freund KB, Takahashi BS. Review of retinal angiomatous proliferation or type 3 neovascularization. Retina 2008;28:375-384. (Pubitemid 351354939)
23. MacTel Web site. Available at: https://secure.emmes.com/emmesweb/ projects/mactel-0. Accessed July 2010.
24. Charbel Issa P, Helb HM, Rohrschneider K, et al. Micro-perimetric assessment of patients with type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 2007;48:3788-3795. (Pubitemid 351261119)
25. Charbel Issa P, Troeger E, Finger R, et al. Structure-function correlation of the human central retina. PLoS One 2010;5:e12864.